O	O	0	5	Human	Human	B-NP	JJ	B-cell_type	2	NMOD	B-cell_type
O	O	6	14	monocyte	monocyte	I-NP	NN	I-cell_type	6	SUB	I-cell_type
O	O	15	22	binding	bind	B-VP	VBG	O	2	NMOD	O
O	O	23	25	to	to	B-PP	TO	O	3	VMOD	O
T1	B-Protein	26	37	fibronectin	fibronectin	B-NP	NN	B-protein	4	PMOD	B-protein
O	O	38	46	enhances	enhance	B-VP	VBZ	O	0	ROOT	O
T2	B-Protein	47	50	IFN	IFN	B-NP	NN	B-protein	9	NMOD	B-protein
T2	I-Protein	50	51	-	-	O	HYPH	I-protein	9	P	I-protein
T2	I-Protein	51	56	gamma	gamma	B-NP	SYM	I-protein	14	NMOD	I-protein
O	O	56	57	-	-	B-PP	HYPH	O	14	P	O
O	O	57	64	induced	induce	B-NP	VBN	O	14	NMOD	O
O	O	65	70	early	early	I-NP	JJ	O	14	NMOD	O
O	O	71	80	signaling	signaling	I-NP	NN	O	14	NMOD	O
O	O	81	87	events	event	I-NP	NNS	O	6	OBJ	O
O	O	87	88	.	.	O	.	O	6	P	O

O	O	90	99	Leukocyte	Leukocyte	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	100	109	integrins	integrin	I-NP	NNS	I-protein	3	SUB	I-protein
O	O	110	113	are	be	B-VP	VBP	O	0	ROOT	O
O	O	114	127	fundamentally	fundamentally	B-ADJP	RB	O	5	AMOD	O
O	O	128	137	important	important	I-ADJP	JJ	O	3	PRD	O
O	O	138	140	in	in	B-PP	IN	O	5	AMOD	O
O	O	141	151	modulating	modulate	B-VP	VBG	O	6	PMOD	O
O	O	152	160	adhesion	adhesion	B-NP	NN	O	7	OBJ	O
O	O	161	163	to	to	B-PP	TO	O	8	NMOD	O
O	O	164	177	extracellular	extracellular	B-NP	JJ	B-protein	12	NMOD	B-protein
O	O	178	184	matrix	matrix	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	185	195	components	component	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	196	199	and	and	B-PP	CC	O	9	PMOD	O
O	O	200	202	to	to	B-PP	TO	O	9	PMOD	O
O	O	203	208	other	other	B-NP	JJ	O	16	NMOD	O
O	O	209	214	cells	cell	I-NP	NNS	O	14	PMOD	O
O	O	214	215	.	.	O	.	O	3	P	O

O	O	216	220	This	This	B-NP	DT	O	5	NMOD	O
O	O	221	229	integrin	integrin	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	229	230	-	-	B-NP	HYPH	O	5	NMOD	O
O	O	230	238	mediated	mediate	I-NP	VBN	O	5	NMOD	O
O	O	239	247	adhesion	adhesion	I-NP	NN	O	6	SUB	O
O	O	248	256	controls	control	B-VP	VBZ	O	0	ROOT	O
O	O	257	266	leukocyte	leukocyte	B-NP	NN	O	6	OBJ	O
O	O	267	273	arrest	arrest	I-NP	NN	O	7	NMOD	O
O	O	274	277	and	and	I-NP	CC	O	7	NMOD	O
O	O	278	291	extravasation	extravasation	I-NP	NN	O	7	NMOD	O
O	O	292	298	during	during	B-PP	IN	O	6	VMOD	O
O	O	299	302	the	the	B-NP	DT	O	13	NMOD	O
O	O	303	308	onset	onset	I-NP	NN	O	11	PMOD	O
O	O	309	311	of	of	B-PP	IN	O	13	NMOD	O
O	O	312	324	inflammatory	inflammatory	B-NP	JJ	O	16	NMOD	O
O	O	325	334	responses	response	I-NP	NNS	O	14	PMOD	O
O	O	334	335	.	.	O	.	O	6	P	O

O	O	336	344	Moreover	Moreover	B-ADVP	RB	O	7	VMOD	O
O	O	344	345	,	,	O	,	O	7	P	O
O	O	346	354	integrin	integrin	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	354	355	-	-	I-NP	HYPH	O	6	NMOD	O
O	O	355	361	ligand	ligand	I-NP	NN	O	6	NMOD	O
O	O	362	374	interactions	interaction	I-NP	NNS	O	7	SUB	O
O	O	375	382	trigger	trigger	B-VP	VBP	O	0	ROOT	O
O	O	383	392	signaling	signaling	B-NP	NN	O	9	NMOD	O
O	O	393	401	pathways	pathway	I-NP	NNS	O	7	OBJ	O
O	O	402	406	that	that	B-NP	WDT	O	9	NMOD	O
O	O	407	410	may	may	B-VP	MD	O	10	SBAR	O
O	O	411	420	influence	influence	I-VP	VB	O	11	VC	O
O	O	421	430	leukocyte	leukocyte	B-NP	NN	O	14	NMOD	O
O	O	431	440	phenotype	phenotype	I-NP	NN	O	16	NMOD	O
O	O	441	444	and	and	I-NP	CC	O	16	NMOD	O
O	O	445	453	function	function	I-NP	NN	O	12	OBJ	O
O	O	454	456	at	at	B-PP	IN	O	12	VMOD	O
O	O	457	462	sites	site	B-NP	NNS	O	17	PMOD	O
O	O	463	465	of	of	B-PP	IN	O	18	NMOD	O
O	O	466	478	inflammation	inflammation	B-NP	NN	O	19	PMOD	O
O	O	478	479	.	.	O	.	O	7	P	O

O	O	480	482	In	In	B-PP	IN	O	7	VMOD	O
O	O	483	486	the	the	B-NP	DT	O	4	NMOD	O
O	O	487	494	current	current	I-NP	JJ	O	4	NMOD	O
O	O	495	502	studies	study	I-NP	NNS	O	1	PMOD	O
O	O	502	503	,	,	O	,	O	7	P	O
O	O	504	506	we	we	B-NP	PRP	O	7	SUB	O
O	O	507	516	evaluated	evaluate	B-VP	VBD	O	0	ROOT	O
O	O	517	520	the	the	B-NP	DT	O	10	NMOD	O
O	O	521	534	combinatorial	combinatorial	I-NP	JJ	O	10	NMOD	O
O	O	535	542	effects	effect	I-NP	NNS	O	7	OBJ	O
O	O	543	545	of	of	B-PP	IN	O	10	NMOD	O
O	O	546	554	monocyte	monocyte	B-NP	NN	O	13	NMOD	O
O	O	555	563	adhesion	adhesion	I-NP	NN	O	17	NMOD	O
O	O	564	567	and	and	I-NP	CC	O	17	NMOD	O
T3	B-Protein	568	571	IFN	IFN	I-NP	NN	B-protein	17	NMOD	B-protein
T3	I-Protein	571	572	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T3	I-Protein	572	577	gamma	gamma	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	578	580	on	on	B-PP	IN	O	10	NMOD	O
O	O	581	594	intracellular	intracellular	B-NP	JJ	O	21	NMOD	O
O	O	595	604	signaling	signaling	I-NP	NN	O	21	NMOD	O
O	O	605	613	pathways	pathway	I-NP	NNS	O	18	PMOD	O
O	O	613	614	.	.	O	.	O	7	P	O

T4	B-Protein	615	618	IFN	IFN	B-NP	NN	B-protein	3	NMOD	B-protein
T4	I-Protein	618	619	-	-	I-NP	HYPH	I-protein	3	NMOD	I-protein
T4	I-Protein	619	624	gamma	gamma	I-NP	NN	I-protein	4	SUB	I-protein
O	O	625	633	triggers	trigger	B-VP	VBZ	O	0	ROOT	O
O	O	634	635	a	a	B-NP	DT	O	11	NMOD	O
O	O	636	640	well	well	I-NP	RB	O	8	AMOD	O
O	O	640	641	-	-	I-NP	HYPH	O	6	AMOD	O
O	O	641	648	defined	define	I-NP	VBN	O	11	NMOD	O
O	O	649	655	signal	signal	I-NP	NN	O	11	NMOD	O
O	O	656	668	transduction	transduction	I-NP	NN	O	11	NMOD	O
O	O	669	676	pathway	pathway	I-NP	NN	O	4	OBJ	O
O	O	676	677	,	,	O	,	O	11	P	O
O	O	678	683	which	which	B-NP	WDT	O	11	NMOD	O
O	O	684	692	although	although	B-SBAR	IN	O	13	DEP	O
O	O	693	696	not	not	B-VP	RB	O	17	VMOD	O
O	O	697	705	directly	directly	I-VP	RB	O	17	VMOD	O
O	O	706	716	stimulated	stimulate	I-VP	VBN	O	14	SBAR	O
O	O	717	719	by	by	B-PP	IN	O	17	VMOD	O
O	O	720	728	monocyte	monocyte	B-NP	NN	O	20	NMOD	O
O	O	729	738	adherence	adherence	I-NP	NN	O	18	PMOD	O
O	O	739	741	to	to	B-PP	TO	O	20	NMOD	O
T5	B-Protein	742	753	fibronectin	fibronectin	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	754	756	or	or	I-NP	CC	O	24	NMOD	O
O	O	757	765	arginine	arginine	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	765	766	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
O	O	766	773	glycine	glycine	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	773	774	-	-	O	HYPH	I-protein	30	P	I-protein
O	O	774	783	aspartate	aspartate	B-NP	NN	I-protein	30	NMOD	I-protein
O	O	784	785	(	(	O	(	I-protein	30	NMOD	I-protein
O	O	785	788	RGD	RGD	B-NP	NN	I-protein	34	NMOD	I-protein
O	O	788	789	)	)	O	)	I-protein	30	NMOD	I-protein
O	O	789	790	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
O	O	790	796	coated	coat	I-NP	VBN	I-protein	34	NMOD	I-protein
O	O	797	806	substrata	substrata	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	806	807	,	,	O	,	O	13	P	O
O	O	808	811	was	be	B-VP	VBD	O	13	SBAR	O
O	O	812	820	enhanced	enhance	I-VP	VBN	O	36	VC	O
O	O	821	834	significantly	significantly	B-ADVP	RB	O	37	VMOD	O
O	O	835	837	in	in	B-PP	IN	O	37	VMOD	O
O	O	838	843	these	these	B-NP	DT	O	44	NMOD	O
O	O	844	850	matrix	matrix	I-NP	NN	O	44	NMOD	O
O	O	850	851	-	-	B-NP	HYPH	O	44	NMOD	O
O	O	851	859	adherent	adherent	I-NP	JJ	B-cell_type	44	NMOD	B-cell_type
O	O	860	865	cells	cell	I-NP	NNS	I-cell_type	39	PMOD	I-cell_type
O	O	865	866	.	.	O	.	O	4	P	O

O	O	867	875	Compared	Compare	B-PP	VBN	O	18	VMOD	O
O	O	876	880	with	with	B-PP	IN	O	1	PMOD	O
O	O	881	890	monocytes	monocyte	B-NP	NNS	B-cell_type	2	PMOD	B-cell_type
O	O	891	893	in	in	B-PP	IN	O	3	NMOD	O
O	O	894	904	suspension	suspension	B-NP	NN	O	4	PMOD	O
O	O	905	907	or	or	O	CC	O	4	DEP	O
O	O	908	916	adherent	adherent	B-ADJP	JJ	O	4	DEP	O
O	O	917	919	on	on	B-PP	IN	O	7	AMOD	O
O	O	920	927	plastic	plastic	B-NP	JJ	O	10	NMOD	O
O	O	928	936	surfaces	surface	I-NP	NNS	O	8	PMOD	O
O	O	936	937	,	,	O	,	O	18	P	O
O	O	938	947	monocytes	monocyte	B-NP	NNS	B-cell_type	18	SUB	B-cell_type
O	O	948	956	adherent	adherent	B-ADJP	JJ	O	12	NMOD	O
O	O	957	959	to	to	B-PP	TO	O	13	AMOD	O
T6	B-Protein	960	971	fibronectin	fibronectin	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	972	974	or	or	I-NP	CC	O	17	NMOD	O
T13	B-Entity	975	978	RGD	RGD	I-NP	NN	O	14	PMOD	O
O	O	979	988	exhibited	exhibit	B-VP	VBD	O	0	ROOT	O
O	O	989	990	a	a	B-NP	DT	O	23	NMOD	O
O	O	991	998	greater	great	I-NP	JJR	O	22	AMOD	O
O	O	999	1003	than	than	B-PP	IN	O	22	AMOD	O
O	O	1004	1013	threefold	threefold	B-NP	JJ	O	23	NMOD	O
O	O	1014	1022	increase	increase	I-NP	NN	O	18	OBJ	O
O	O	1023	1025	in	in	B-PP	IN	O	23	NMOD	O
O	O	1026	1032	steady	steady	B-NP	JJ	O	27	NMOD	O
O	O	1033	1038	state	state	I-NP	NN	O	27	NMOD	O
O	O	1039	1045	levels	level	I-NP	NNS	O	24	PMOD	O
O	O	1046	1048	of	of	B-PP	IN	O	27	NMOD	O
T7	B-Protein	1049	1052	IFN	IFN	B-NP	NN	B-protein	34	NMOD	B-protein
T7	I-Protein	1052	1053	-	-	O	HYPH	O	29	P	O
T7	I-Protein	1053	1058	gamma	gamma	O	SYM	B-RNA	34	NMOD	B-RNA
O	O	1058	1059	-	-	O	HYPH	I-RNA	34	NMOD	I-RNA
O	O	1059	1066	induced	induce	B-NP	VBN	I-RNA	34	NMOD	I-RNA
O	O	1067	1071	mRNA	mRNA	I-NP	NN	I-RNA	28	PMOD	I-RNA
O	O	1072	1075	for	for	B-PP	IN	O	23	NMOD	O
O	O	1076	1079	the	the	B-NP	DT	O	41	NMOD	O
T8	B-Protein	1080	1084	high	high	I-NP	JJ	B-protein	41	NMOD	B-protein
T8	I-Protein	1085	1093	affinity	affinity	I-NP	NN	I-protein	41	NMOD	I-protein
T8	I-Protein	1094	1096	Fc	Fc	I-NP	NN	I-protein	41	NMOD	I-protein
T8	I-Protein	1097	1104	gammaRI	gammaRI	I-NP	NN	I-protein	41	NMOD	I-protein
T8	I-Protein	1105	1113	receptor	receptor	I-NP	NN	I-protein	35	PMOD	I-protein
O	O	1113	1114	.	.	O	.	O	18	P	O

O	O	1115	1117	By	By	B-PP	IN	O	11	VMOD	O
O	O	1118	1133	electrophoretic	electrophoretic	B-NP	JJ	O	5	NMOD	O
O	O	1134	1142	mobility	mobility	I-NP	NN	O	5	NMOD	O
O	O	1143	1148	shift	shift	I-NP	NN	O	5	NMOD	O
O	O	1149	1155	assays	assay	I-NP	NNS	O	1	PMOD	O
O	O	1155	1156	,	,	O	,	O	11	P	O
O	O	1157	1161	this	this	B-NP	DT	O	8	NMOD	O
O	O	1162	1170	increase	increase	I-NP	NN	O	11	SUB	O
O	O	1171	1173	in	in	B-PP	IN	O	8	NMOD	O
O	O	1174	1178	mRNA	mRNA	B-NP	NN	B-RNA	9	PMOD	B-RNA
O	O	1179	1182	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1183	1193	associated	associate	I-VP	VBN	O	11	VC	O
O	O	1194	1198	with	with	B-PP	IN	O	12	VMOD	O
O	O	1199	1200	a	a	B-NP	DT	O	21	NMOD	O
O	O	1201	1202	5	5	I-NP	CD	O	16	NMOD	O
O	O	1202	1203	-	-	I-NP	HYPH	O	20	AMOD	O
O	O	1204	1206	to	to	B-PP	TO	O	20	AMOD	O
O	O	1207	1209	10	10	B-NP	CD	O	20	AMOD	O
O	O	1209	1210	-	-	I-NP	HYPH	O	20	AMOD	O
O	O	1210	1214	fold	fold	I-NP	JJ	O	21	NMOD	O
O	O	1215	1223	increase	increase	I-NP	NN	O	13	PMOD	O
O	O	1224	1226	in	in	B-PP	IN	O	21	NMOD	O
O	O	1227	1230	the	the	B-NP	DT	O	22	PMOD	O
T9	B-Protein	1231	1236	STAT1	STAT1	I-NP	NN	B-protein	23	DEP	B-protein
T14	B-Entity	1236	1237	-	-	O	HYPH	O	24	P	O
T14	I-Entity	1237	1247	containing	contain	B-VP	VBG	O	24	NMOD	O
T14	I-Entity	1248	1251	DNA	DNA	B-NP	NN	B-protein	30	NMOD	B-protein
T14	I-Entity	1251	1252	-	-	O	HYPH	I-protein	27	P	I-protein
T14	I-Entity	1252	1259	binding	bind	B-VP	VBG	I-protein	30	NMOD	I-protein
T14	I-Entity	1260	1267	complex	complex	B-NP	NN	I-protein	26	OBJ	I-protein
O	O	1268	1272	that	that	B-NP	WDT	O	30	NMOD	O
O	O	1273	1278	binds	bind	B-VP	VBZ	O	31	SBAR	O
O	O	1279	1281	to	to	B-PP	TO	O	32	VMOD	O
T15	B-Entity	1282	1284	Fc	Fc	B-NP	NN	B-DNA	37	NMOD	B-DNA
T15	I-Entity	1285	1292	gammaRI	gammaRI	I-NP	NN	I-DNA	37	NMOD	I-DNA
T15	I-Entity	1293	1301	promoter	promoter	I-NP	NN	I-DNA	37	NMOD	I-DNA
T15	I-Entity	1302	1310	elements	element	I-NP	NNS	I-DNA	33	PMOD	I-DNA
O	O	1310	1311	.	.	O	.	O	11	P	O

O	O	1312	1323	Furthermore	Furthermore	B-ADVP	RB	O	15	VMOD	O
O	O	1323	1324	,	,	O	,	O	15	P	O
O	O	1325	1328	the	the	B-NP	DT	O	5	NMOD	O
T16	B-Entity	1329	1337	tyrosine	tyrosine	I-NP	NN	O	5	NMOD	O
O	O	1338	1353	phosphorylation	phosphorylation	I-NP	NN	O	15	SUB	O
O	O	1354	1356	of	of	B-PP	IN	O	5	NMOD	O
T10	B-Protein	1357	1362	STAT1	STAT1	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	1363	1366	and	and	O	CC	O	14	NMOD	O
O	O	1367	1370	the	the	B-NP	DT	O	11	NMOD	O
O	O	1371	1379	tyrosine	tyrosine	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	1380	1387	kinases	kinase	I-NP	NNS	I-protein	14	NMOD	I-protein
T11	B-Protein	1388	1392	JAK1	JAK1	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	1393	1396	and	and	I-NP	CC	O	14	NMOD	O
T12	B-Protein	1397	1401	JAK2	JAK2	I-NP	NN	B-protein	6	PMOD	B-protein
O	O	1402	1405	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1406	1414	enhanced	enhance	I-VP	VBN	O	15	VC	O
O	O	1415	1428	significantly	significantly	B-ADVP	RB	O	16	VMOD	O
O	O	1429	1431	in	in	B-PP	IN	O	16	VMOD	O
T17	B-Entity	1432	1435	RGD	RGD	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	1435	1436	-	-	B-NP	HYPH	O	22	NMOD	O
O	O	1436	1444	adherent	adherent	I-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	1445	1454	monocytes	monocyte	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	1455	1463	compared	compare	B-PP	VBN	O	16	VMOD	O
O	O	1464	1468	with	with	B-PP	IN	O	23	PMOD	O
O	O	1469	1476	control	control	B-NP	NN	B-cell_type	26	NMOD	B-cell_type
O	O	1477	1482	cells	cell	I-NP	NNS	I-cell_type	24	PMOD	I-cell_type
O	O	1482	1483	.	.	O	.	O	15	P	O

O	O	1484	1489	These	These	B-NP	DT	O	2	NMOD	O
O	O	1490	1497	results	result	I-NP	NNS	O	3	SUB	O
O	O	1498	1505	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1506	1507	a	a	B-NP	DT	O	6	NMOD	O
O	O	1508	1513	novel	novel	I-NP	JJ	O	6	NMOD	O
O	O	1514	1523	mechanism	mechanism	I-NP	NN	O	3	OBJ	O
O	O	1524	1526	by	by	B-PP	IN	O	6	NMOD	O
O	O	1527	1532	which	which	B-NP	WDT	O	7	PMOD	O
O	O	1533	1541	integrin	integrin	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1541	1542	-	-	B-VP	HYPH	O	13	NMOD	O
O	O	1542	1550	mediated	mediate	B-NP	VBN	O	13	NMOD	O
O	O	1551	1555	cell	cell	I-NP	NN	O	13	NMOD	O
O	O	1556	1564	adhesion	adhesion	I-NP	NN	O	14	SUB	O
O	O	1565	1568	can	can	B-VP	MD	O	7	SBAR	O
O	O	1569	1577	modulate	modulate	I-VP	VB	O	14	VC	O
O	O	1578	1581	the	the	B-NP	DT	O	17	NMOD	O
O	O	1582	1591	magnitude	magnitude	I-NP	NN	O	15	OBJ	O
O	O	1592	1594	of	of	B-PP	IN	O	17	NMOD	O
O	O	1595	1603	cytokine	cytokine	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	1603	1604	-	-	B-NP	HYPH	O	24	P	O
O	O	1604	1611	induced	induce	I-NP	VBN	O	24	NMOD	O
O	O	1612	1618	signal	signal	I-NP	NN	O	24	NMOD	O
O	O	1619	1631	transduction	transduction	I-NP	NN	O	24	NMOD	O
O	O	1632	1640	pathways	pathway	I-NP	NNS	O	18	PMOD	O
O	O	1640	1641	,	,	O	,	O	14	P	O
O	O	1642	1649	thereby	thereby	B-VP	RB	O	27	VMOD	O
O	O	1650	1660	amplifying	amplify	I-VP	VBG	O	14	VMOD	O
O	O	1661	1669	cellular	cellular	B-NP	JJ	O	29	NMOD	O
O	O	1670	1676	events	event	I-NP	NNS	O	27	OBJ	O
O	O	1677	1684	leading	lead	B-VP	VBG	O	29	NMOD	O
O	O	1685	1687	to	to	B-PP	TO	O	30	VMOD	O
O	O	1688	1696	monocyte	monocyte	B-NP	NN	O	31	PMOD	O
O	O	1697	1707	activation	activation	I-NP	NN	O	32	NMOD	O
O	O	1708	1711	and	and	O	CC	O	32	NMOD	O
O	O	1712	1724	inflammation	inflammation	B-NP	NN	O	32	NMOD	O
O	O	1724	1725	.	.	O	.	O	3	P	O
